|
"tsai yh"的相關文件
顯示項目 56-65 / 161 (共17頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺北醫學大學 |
2014 |
Interferon-γ suppresses activin A/NF-E2 induction of erythroid gene expression through the NF-κB/c-Jun pathway
|
Lee, WH;Chung, MH;Tsai, YH;Chang, JL;Huang, HM |
| 臺北醫學大學 |
2014 |
Interferon-γ suppresses activin A/NF-E2 induction of erythroid gene expression through the NF-κB/c-Jun pathway
|
Lee, WH;Chung, MH;Tsai, YH;Chang, JL;Huang, HM |
| 臺北醫學大學 |
2014 |
Effects of 6-Hydroxyflavone on Osteoblast Differentiation in MC3T3-E1 Cells
|
Lai, CH;Wu, YW;Yeh, SD;Lin, YH;Tsai, YH |
| 臺北醫學大學 |
2014 |
Effects of 6-Hydroxyflavone on Osteoblast Differentiation in MC3T3-E1 Cells
|
Lai, CH;Wu, YW;Yeh, SD;Lin, YH;Tsai, YH |
| 臺北醫學大學 |
2014 |
Abelson Helper Integration Site-1 as a Biomarker for Alzheimer's Disease
|
Lin, YF;Yang, LY;Hsu, IU;Tsai, YH;Chang, FY;Wang, ST;Sheu, JJ |
| 國家衛生研究院 |
2013-05 |
Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy
|
Chang, CH;Hsiao, CF;Yeh, YM;Chang, GC;Tsai, YH;Chen, YM;Huang, MS;Chen, HL;Li, YJ;Yang, PC;Chen, CJ;Hsiung, CA;Su, WC |
| 國家衛生研究院 |
2013-03 |
Risk factors for primary lung cancer among never smokers by gender in a matched case-control study
|
Lo, YL;Hsiao, CF;Chang, GC;Tsai, YH;Huang, MS;Su, WC;Chen, YM;Hsin, CW;Chang, CH;Yang, PC;Chen, CJ;Hsiung, CA |
| 國家衛生研究院 |
2013-03 |
EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: Analysis from a genome-wide association study in never-smoking women
|
Chen, KY;Hsiao, CF;Chang, GC;Tsai, YH;Su, WC;Chen, YM;Huang, MS;Hsiung, CA;Chen, CJ;Yang, PC;Group, GS |
| 國家衛生研究院 |
2013-01 |
EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients
|
Yang, SY;Yang, TY;Li, YJ;Chen, KC;Liao, KM;Hsu, KH;Tsai, CR;Chen, CY;Hsu, CP;Hsia, JY;Chuang, CY;Tsai, YH;Chen, KY;Huang, MS;Su, WC;Chen, YM;Hsiung, CA;Shen, CY;Chang, GC;Yang, PC;Chen, CJ |
| 元培科技大學 |
2013 |
Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery.
|
Fang, YP;Wu, PC;Huang, YB;Tzeng, CC;Chen, YL;Hung, YH;Tsai, MJ;Tsai, YH. |
顯示項目 56-65 / 161 (共17頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
